BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 38199869)

  • 21. Laparoscopic and open postchemotherapy retroperitoneal lymph node dissection in patients with advanced testicular cancer--a single center analysis.
    Busch J; Magheli A; Erber B; Friedersdorff F; Hoffmann I; Kempkensteffen C; Weikert S; Miller K; Schrader M; Hinz S
    BMC Urol; 2012 May; 12():15. PubMed ID: 22651395
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outcomes of post-chemotherapy robot-assisted retroperitoneal lymph node dissection in testicular cancer: multi-institutional study.
    Abdul-Muhsin H; Rocco N; Navaratnam A; Woods M; L'Esperance J; Castle E; Stroup S
    World J Urol; 2021 Oct; 39(10):3833-3838. PubMed ID: 33959785
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A New Model to Predict Benign Histology in Residual Retroperitoneal Masses After Chemotherapy in Nonseminoma.
    Leão R; Nayan M; Punjani N; Jewett MAS; Fadaak K; Garisto J; Lewin J; Atenafu EG; Sweet J; Anson-Cartwright L; Boström P; Chung P; Warde P; Bedard PL; Bagrodia A; Freifeld Y; Power N; Winquist E; Hamilton RJ
    Eur Urol Focus; 2018 Dec; 4(6):995-1001. PubMed ID: 29428550
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical outcome of postchemotherapy retroperitoneal lymph node dissection and predicting retroperitoneal histology in advanced nonseminomatous germ cell tumours of the testis].
    Li XD; Guo SJ; Chen SL; Liu ZF; Dong P; Zhang ZL; Jiang LJ; Yao K; Li YH; Han H; Qin ZK; Liu ZW; Zhou FJ
    Zhonghua Wai Ke Za Zhi; 2017 Aug; 55(8):603-607. PubMed ID: 28789511
    [No Abstract]   [Full Text] [Related]  

  • 25. Excision of Postchemotherapy Residual Retroperitoneal Mass in Testicular Cancer.
    Nauman M; Hussain M; Kumar P; Mohsin R; Sultan G; Hashmi A
    J Coll Physicians Surg Pak; 2022 Aug; 32(8):1089-1091. PubMed ID: 35932143
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Midline Extraperitoneal Approach to Retroperitoneal Lymph Node Dissection in Testicular Cancer: Minimizing Surgical Morbidity.
    Syan-Bhanvadia S; Bazargani ST; Clifford TG; Cai J; Miranda G; Daneshmand S
    Eur Urol; 2017 Nov; 72(5):814-820. PubMed ID: 28325537
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of postchemotherapy surgery in managing metastatic germ cell tumors.
    Beck SD
    Cancer; 2007 Dec; 110(12):2601-3, i. PubMed ID: 17948907
    [No Abstract]   [Full Text] [Related]  

  • 28. Robotic Assisted Retroperitoneal Lymph Node Dissection for Small Volume Metastatic Testicular Cancer.
    Hiester A; Nini A; Arsov C; Buddensieck C; Albers P
    J Urol; 2020 Dec; 204(6):1242-1248. PubMed ID: 32717162
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Post-chemotherapy nerve-sparing laparoscopic retroperitoneal lymph node dissection in stage IIB testicular cancer.
    Kimura Y; Nakamura T; Kawauchi A; Kawabata G; Hongo F; Miki T
    Int J Urol; 2013 Aug; 20(8):837-41. PubMed ID: 23305547
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oncological outcome and complications of post-chemotherapy retroperitoneal surgery in non-seminomatous germ cell tumours - a systematic review.
    Rosenvilde JJ; Pedersen GL; Bandak M; Lauritsen J; Kreiberg M; Wagner T; Aagaard M; Daugaard G
    Acta Oncol; 2021 Jun; 60(6):695-703. PubMed ID: 33819117
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Robot-assisted Laparoscopic Retroperitoneal Lymph Node Dissection for Testicular Cancer: Evolution of the Technique.
    Stepanian S; Patel M; Porter J
    Eur Urol; 2016 Oct; 70(4):661-667. PubMed ID: 27068395
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Major complications of post-chemotherapy retroperitoneal lymph node dissection in a contemporary cohort of patients with testicular cancer and a review of the literature.
    Ruf CG; Krampe S; Matthies C; Anheuser P; Nestler T; Simon J; Isbarn H; Dieckmann KP
    World J Surg Oncol; 2020 Sep; 18(1):253. PubMed ID: 32972425
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outcomes after resection of postchemotherapy residual neck mass in patients with germ cell tumors--an update.
    Gupta A; Feifer AH; Gotto GT; Kraus D; Motzer R; Bosl GJ; Bajorin D; Feldman DR; Carver B; Sheinfeld J
    Urology; 2011 Mar; 77(3):655-9. PubMed ID: 21377010
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Postchemotherapy laparoscopic retroperitoneal lymph node dissection for nonseminomatous germ cell tumors infiltrating the great vessels.
    Aufderklamm S; Todenhöfer T; Hennenlotter J; Mischinger J; Böttge J; Rausch S; Halalsheh O; Stenzl A; Gakis G; Schwentner C
    J Endourol; 2014 Jun; 28(6):668-74. PubMed ID: 24422683
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Perioperative complications and oncological outcomes of post-chemotherapy retroperitoneal lymph node dissection in patients with germ cell cancer at two high-volume university centres in Switzerland - a retrospective chart review.
    Notarfrancesco M; Fankhauser CD; Lorch A; Ardizzone D; Helnwein S; Hoch D; Hermanns T; Thalmann G; Beyer J
    Swiss Med Wkly; 2023 Apr; 153():40053. PubMed ID: 37080191
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety and Early Oncologic Effectiveness of Primary Robotic Retroperitoneal Lymph Node Dissection for Nonseminomatous Germ Cell Testicular Cancer.
    Pearce SM; Golan S; Gorin MA; Luckenbaugh AN; Williams SB; Ward JF; Montgomery JS; Hafez KS; Weizer AZ; Pierorazio PM; Allaf ME; Eggener SE
    Eur Urol; 2017 Mar; 71(3):476-482. PubMed ID: 27234998
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Role of Postchemotherapy Surgery in Germ Cell Tumors.
    Chéry L; Dash A
    Urol Clin North Am; 2015 Aug; 42(3):331-42. PubMed ID: 26216820
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Contemporary management of postchemotherapy testis cancer.
    Daneshmand S; Albers P; Fosså SD; Heidenreich A; Kollmannsberger C; Krege S; Nichols C; Oldenburg J; Wood L
    Eur Urol; 2012 Nov; 62(5):867-76. PubMed ID: 22938868
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Post-chemotherapy Laparoscopic Retroperitoneal Lymph Node Dissection for Mixed Malignant Germ Cell Testicular Tumors.
    Pickersgill NA; Raval NS; Kim EH; Black RG; Du K; Figenshau RS
    Clin Genitourin Cancer; 2021 Jun; 19(3):273.e1-273.e5. PubMed ID: 33139148
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical Outcome of Patients with Fibrosis/Necrosis at Post-Chemotherapy Retroperitoneal Lymph Node Dissection for Advanced Germ Cell Tumors.
    Mano R; Becerra MF; Carver BS; Bosl GJ; Motzer RJ; Bajorin DF; Feldman DR; Sheinfeld J
    J Urol; 2017 Feb; 197(2):391-397. PubMed ID: 27720783
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.